The Traderszone Network

Published in TZ Latest News 22 December, 2014 by The TZ Newswire Staff

The Wall Street Journal: FDA approves Bristol-Myers’s skin cancer treatment Opdivo

Company expected to charge $12,500 a month for drug to fight lethal late stage melanoma.
read more